Literature DB >> 2127549

Sodium nitroprusside modulates the fibrinolytic system in the rabbit.

P S Lidbury1, R Korbut, J R Vane.   

Abstract

1. We have investigated the effect of sodium nitroprusside (NP) and glyceryl trinitrate (GTN) on fibrinolysis in anaesthetized rabbits ex vivo and in vitro by measurement of euglobulin clot lysis time (ECLT), plasma levels of tissue plasminogen activator (t-PA) activity, plasma t-PA antigen levels and plasminogen activator inhibitor (PAI-1) activity. 2. In vivo, NP (30 micrograms kg-1), GTN (30 micrograms kg-1) and prostacyclin (3 micrograms kg-1) caused similar transient decreases in left ventricular systolic pressure. However, while prostacyclin induced near-maximal inhibition of ex vivo platelet aggregation, NP or GTN had no effect. 3. Ex vivo, NP caused a significant decrease in ECLT and an increase in plasma t-PA activity. 4. Intravenous co-administration of t-PA (30 micrograms kg-1) with NP caused substantial prolongation of plasma t-PA activity, without affecting t-PA antigen levels. 5. In whole blood in vitro, NP (30 micrograms kg-1) prevented the time-dependent increase in PAI-1 activity and inhibited inactivation of added t-PA (10 ng ml-1). 6. We propose that NP exhibited fibrinolytic activity through increased t-PA activity as a result of inhibition of PAI-1 release from platelets. These results could have important therapeutic consequences when t-PA and nitrate treatments are combined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2127549      PMCID: PMC1917738          DOI: 10.1111/j.1476-5381.1990.tb14115.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Methods for the evaluation of human fibrinolysis; studies with two combined technics.

Authors:  K N VON KAULLA; R L SCHULTZ
Journal:  Am J Clin Pathol       Date:  1958-02       Impact factor: 2.493

2.  Studies on an inhibitor of plasminogen activators in human platelets.

Authors:  J Murray; G P Crawford; D Ogston; A S Douglas
Journal:  Br J Haematol       Date:  1974-04       Impact factor: 6.998

3.  Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators.

Authors:  B T Mellion; L J Ignarro; E H Ohlstein; E G Pontecorvo; A L Hyman; P J Kadowitz
Journal:  Blood       Date:  1981-05       Impact factor: 22.113

4.  Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.

Authors:  L A Erickson; M H Ginsberg; D J Loskutoff
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

5.  Fibrinolytic activity of 6-keto-prostaglandin E1.

Authors:  R Korbut; A Byrska-Danek; R J Gryglewski
Journal:  Thromb Haemost       Date:  1983-12-30       Impact factor: 5.249

Review 6.  Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.

Authors:  S Moncada
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

7.  A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris.

Authors:  H K Gold; J A Johns; R C Leinbach; T Yasuda; E Grossbard; R Zusman; D Collen
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

8.  Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.

Authors:  J E Tateson; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1977-03

9.  Inhibition of platelet function by organic nitrate vasodilators.

Authors:  A I Schafer; R W Alexander; R I Handin
Journal:  Blood       Date:  1980-04       Impact factor: 22.113

10.  Studies on the release of a plasminogen activator inhibitor by human platelets.

Authors:  E K Kruithof; C Tran-Thang; F Bachmann
Journal:  Thromb Haemost       Date:  1986-04-30       Impact factor: 5.249

View more
  6 in total

1.  Attenuation by prolonged nitric oxide synthase inhibition of the enhancement of fibrinolysis caused by environmental stress in the rat.

Authors:  A Kawabata; T Hata
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

2.  Evidence that endogenous nitric oxide modulates plasma fibrinogen levels in the rat.

Authors:  A Kawabata
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

3.  S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme.

Authors:  J S Stamler; D I Simon; O Jaraki; J A Osborne; S Francis; M Mullins; D Singel; J Loscalzo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

4.  Effects of an oral dose of isosorbide dinitrate on platelet function and fibrinolysis in healthy volunteers.

Authors:  N H Wallén; P T Larsson; A Bröijersén; A Andersson; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

5.  The effect of nitric oxide synthase inhibition on the plasma fibrinolytic system in septic shock in rats.

Authors:  R Korbut; T D Warner; R J Gryglewski; J R Vane
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

6.  Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine.

Authors:  Mirjana Stupnisek; Antonio Kokot; Domagoj Drmic; Masa Hrelec Patrlj; Anita Zenko Sever; Danijela Kolenc; Bozo Radic; Jelena Suran; Davor Bojic; Aleksandar Vcev; Sven Seiwerth; Predrag Sikiric
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.